Logos Technologies has received a small business innovation research (SBIR) grant from DARPA (the Defense Advanced Research Projects Agency) to develop a military-use hybrid-electric motorcycle with near-silent capability. When fully matured, the technology will allow small, distributed military teams to move long distances quickly and stealthily across harsh enemy terrain.

Developed in partnership with San Francisco-based all-electric motorcycle producer BRD, the platform will combine Logos Technologies’ quieted, multifuel hybrid-electric power system with a cutting-edge, off-road electric motorcycle platform developed by BRD. This initiative will be the first time that a two-wheel-drive, multifuel hybrid capability has been integrated into a full-size off-road motorcycle.

“Quieted, all-wheel-drive capability at extended range in a lightweight, rugged, single-track vehicle could support the successful operations of U.S. expeditionary and special forces in extreme terrain conditions and contested environments,” said Wade Pulliam, manager of advanced concepts at Logos Technologies. “With a growing need to operate small units far from logistical support, the military may increasingly rely on adaptable, efficient technologies like this hybrid-electric motorcycle.”

Beyond the efficiency and mobility improvements the design aims to bring, the hybrid-electric approach also allows for extended periods of near-silent, electric-only-propulsion as well as the generation of supplemental electric power for use by personnel in the field.

“Our advanced yet affordable offering will provide operators the near-silent capability and ease of operation, of an all-electric vehicle along with the adaptable power generation and extended range of a multifuel internal combustion engine,” continues Pulliam. “By utilizing our team’s experience developing similar hybrid-powered projects and first-in-class electric motorcycles, the Logos Technologies-BRD partnership seeks to deliver a highly capable low-risk and proven product.”

NO COMMENTS

LEAVE A REPLY